Expat Sydneysider, 24, is behind a $300m US start-up

SYDNEY: At just 24, Australian entrepreneur Max Marchione has Silicon Valley at his ... read more

Mayne earnings outlook rosy despite threat of Trump tariffs

MELBOURNE: Drugmaker Mayne Pharma, which is the subject of a $672m foreign takeover ... read more

Heart device maker wins FDA approval in major corporate boost

SYDNEY: EBR Systems, the heart device hopeful heavily backed by high-profile investors including, ... read more

Chemist billionaire in $297m Sigma selldown bolsters ASX turnover

MELBOURNE: Damien Gance, a director of Sigma Health and Chemist Warehouse co-founder Sam ... read more